Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general … Read more
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) - Total Assets
Latest total assets as of June 2025: CN¥1.86 Billion CNY
Based on the latest financial reports, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) holds total assets worth CN¥1.86 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Total Assets Trend (2019–2024)
This chart illustrates how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's total assets of CN¥1.86 Billion consist of 56.8% current assets and 43.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.3% |
| Accounts Receivable | CN¥272.46 Million | 15.6% |
| Inventory | CN¥229.86 Million | 13.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥81.72 Million | 4.7% |
| Goodwill | CN¥43.06 Million | 2.5% |
Asset Composition Trend (2019–2024)
This chart illustrates how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's current assets represent 56.8% of total assets in 2024, a decrease from 58.4% in 2019.
- Cash Position: Cash and equivalents constituted 15.3% of total assets in 2024, down from 27.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 16.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 15.6% of total assets.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Competitors by Total Assets
Key competitors of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A generates $ 1.20 in net profit.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.55 | 6.04 | 22.77 |
| Quick Ratio | 1.91 | 4.56 | 20.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥623.91 Million | CN¥ 802.16 Million | CN¥ 938.08 Million |
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.57 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | 9.6% |
| Total Assets | CN¥1.75 Billion |
| Market Capitalization | $445.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's assets below their book value (0.26 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's assets grew by 9.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2019–2024)
The table below shows the annual total assets of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.75 Billion | +9.63% |
| 2023-12-31 | CN¥1.60 Billion | +9.24% |
| 2022-12-31 | CN¥1.46 Billion | +8.22% |
| 2021-12-31 | CN¥1.35 Billion | +113.63% |
| 2020-12-31 | CN¥631.59 Million | +5.34% |
| 2019-12-31 | CN¥599.55 Million | -- |